Medicine and Dentistry
Antithrombotic
12%
Apixaban
37%
Assay
75%
Assessment
12%
Consensus
12%
Dabigatran
37%
Direct Thrombin Inhibitor
25%
Drug Effect
25%
Ecarin
25%
Edoxaban
12%
Factor X
12%
Laboratory
12%
Laboratory Assessment
12%
Laboratory Test
12%
Monitoring
12%
Partial Thromboplastin Time
25%
Prothrombin Time
25%
Quantitative Assay
25%
Recognition
12%
Rivaroxaban
37%
Screening
25%
Thrombin
12%
Thrombin Time
25%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
12%
Apixaban
37%
Blood Clotting Factor 10
12%
Dabigatran
37%
Direct Oral Anticoagulant
100%
Ecarin
25%
Edoxaban
12%
Rivaroxaban
37%
Thrombin
12%
Thrombin Inhibitor
25%
Biochemistry, Genetics and Molecular Biology
Consensus
12%
Drug Effect
25%
Ecarin
25%
Factor X
12%
Laboratory Test
12%
Partial Thromboplastin Time
25%
Prothrombin Time
25%
Quantitative Technique
12%
Recognition
12%
Rivaroxaban
37%
Screening
25%
Thrombin
25%
Thrombin Time
25%
Time
12%
Neuroscience
Anticoagulant
50%
Antithrombotic Agents
12%
Apixaban
37%
Dabigatran
37%
Direct Thrombin Inhibitor
12%
Ecarin
25%
Edoxaban
12%
Factor X
12%
Recognition
12%
Rivaroxaban
37%
Thrombin
25%
Immunology and Microbiology
Consensus
12%
Drug Effect
25%
Laboratory Test
12%
Recognition
12%
Screening
25%
Thrombin
25%
Time
12%